The dsd-LIFE consortium consists of 16 participating institutions based in six different EU member states which are: Germany, France, UK, Sweden, The Netherlands and Poland.

It will mobilize the synergies of the major relevant European research groups to aim for sustainable improvement of clinical and care for patients with difference or disorder in sex development (DSD) on European level. The consortium is formed by consists of 15 experienced and well-known international scientists in the areas of endocrinology, psychology and ethics.

Excellent research standards and high inclusion of patients resp. patient support groups will be the basis for the dsd-LIFE Project.